Cargando…

Comparative Effectiveness of Generic Atorvastatin and Lipitor(®) in Patients Hospitalized with an Acute Coronary Syndrome

BACKGROUND: Although generic medications are approved based on bioequivalence with brand‐name medications, there remains substantial concern regarding their clinical effectiveness and safety. Lipitor(®), available as generic atorvastatin, is one of the most commonly prescribed statins. Therefore, we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jackevicius, Cynthia A., Tu, Jack V., Krumholz, Harlan M., Austin, Peter C., Ross, Joseph S., Stukel, Therese A., Koh, Maria, Chong, Alice, Ko, Dennis T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859299/ https://www.ncbi.nlm.nih.gov/pubmed/27098970 http://dx.doi.org/10.1161/JAHA.116.003350

Ejemplares similares

Atorvastatin (Lipitor) by MCR
por: Zarganes-Tzitzikas, Tryfon, et al.
Publicado: (2019)

Generic atorvastatin is as effective as the brand-name drug (LIPITOR(®)) in lowering cholesterol levels: a cross-sectional retrospective cohort study
por: Loch, Alexander, et al.
Publicado: (2017)

Comparative effectiveness of ACE inhibitors and angiotensin receptor blockers in patients with prior myocardial infarction
por: Ko, Dennis, et al.
Publicado: (2019)

Submissions from the SPRINT Data Analysis Challenge on clinical risk prediction: a cross-sectional evaluation
por: Jackevicius, Cynthia A, et al.
Publicado: (2019)

Atorvastatin (Lipitor) attenuates the effects of aspirin on pancreatic cancerogenesis and the chemotherapeutic efficacy of gemcitabine on pancreatic cancer by promoting M2 polarized tumor associated macrophages
por: Liu, Qiaofei, et al.
Publicado: (2016)

Hospital‐Level Variation in Ticagrelor Use in Patients With Acute Coronary Syndrome
por: Ozaki, Aya F., et al.
Publicado: (2022)

Prescribing patterns and factors associated with sodium–glucose cotransporter-2 inhibitor prescribing in patients with diabetes mellitus and atherosclerotic cardiovascular disease
por: Ozaki, Aya F., et al.
Publicado: (2023)

Factors associated with door-in to door-out delays among ST-segment elevation myocardial infarction (STEMI) patients transferred for primary percutaneous coronary intervention: a population-based cohort study in Ontario, Canada
por: Shi, Oumin, et al.
Publicado: (2018)

Association of high-density lipoprotein cholesterol with non-fatal cardiac and non-cardiac events: a CANHEART substudy
por: Wijeysundera, Harindra C, et al.
Publicado: (2017)

Structural homologies between phenformin, lipitor and gleevec aim the same metabolic oncotarget in leukemia and melanoma
por: Somlyai, Gábor, et al.
Publicado: (2017)

Projected Real‐World Effectiveness of Using Aggressive Low‐Density Lipoprotein Cholesterol Targets Among Elderly Statin Users Following Acute Coronary Syndromes in Canada
por: Alter, David A., et al.
Publicado: (2018)

Prescribing of two potentially interacting cardiovascular medications in atrial fibrillation patients on direct oral anticoagulants
por: Shurrab, Mohammed, et al.
Publicado: (2021)

Efficacy of Generic Atorvastatin in a Real-World Setting
por: Manasirisuk, Panisa, et al.
Publicado: (2021)

Eligibility, Clinical Outcomes, and Budget Impact of PCSK9 Inhibitor Adoption: The CANHEART PCSK9 Study
por: Ko, Dennis T., et al.
Publicado: (2018)

Outcomes in patients with heart failure treated in hospitals with varying admission rates: population-based cohort study
por: Bhatia, R Sacha, et al.
Publicado: (2014)

Socioeconomic Status, Functional Recovery, and Long-Term Mortality among Patients Surviving Acute Myocardial Infarction
por: Alter, David A., et al.
Publicado: (2013)

Impact of clinical urgency, physician supply and procedural capacity on regional variations in wait times for coronary angiography
por: Wijeysundera, Harindra C, et al.
Publicado: (2010)

Obesity, lifestyle risk-factors, and health service outcomes among healthy middle-aged adults in Canada
por: Alter, David A, et al.
Publicado: (2012)

The impact of a physician detailing and sampling program for generic atorvastatin: an interrupted time series analysis
por: Worthington, Heather C., et al.
Publicado: (2017)

Outcomes of Women and Men With Acute Coronary Syndrome Treated With and Without Percutaneous Coronary Revascularization
por: Udell, Jacob A., et al.
Publicado: (2017)

The Impact of Generic Clopidogrel Bisulfate on Platelet Inhibition in Patients with Coronary Artery Stents: Results of the ACCEL-GENERIC Study
por: Jeong, Young-Hoon, et al.
Publicado: (2010)

Cost-effectiveness of rosuvastatin in comparison with generic atorvastatin and simvastatin in a Swedish population at high risk of cardiovascular events
por: Gandhi, Sanjay K, et al.
Publicado: (2012)

Statin Use and Stroke Rate in Older Adults With Atrial Fibrillation: A Population‐Based Cohort Study
por: Shweikialrefaee, Bisan, et al.
Publicado: (2023)

Therapeutic effects of atorvastatin and ezetimibe compared with double-dose atorvastatin in very elderly patients with acute coronary syndrome
por: Liu, Zhi, et al.
Publicado: (2017)

Association of Diabetes Duration and Glycemic Control With Stroke Rate in Patients With Atrial Fibrillation and Diabetes: A Population‐Based Cohort Study
por: Abdel‐Qadir, Husam, et al.
Publicado: (2022)

Postmarket Clinical Evidence for High-Risk Therapeutic Medical Devices Receiving Food and Drug Administration Premarket Approval in 2010 and 2011
por: Rathi, Vinay K., et al.
Publicado: (2020)

Atorvastatin improves coronary flow and endothelial function in patients with coronary slow flow
por: Niu, Hongmei, et al.
Publicado: (2018)

Trends in the likelihood of receiving percutaneous coronary intervention in a low-volume hospital and disparities by sociodemographic communities
por: Wang, Christina, et al.
Publicado: (2023)

Prediction of Emergent Heart Failure Death by Semi-Quantitative Triage Risk Stratification
por: Van Spall, Harriette G. C., et al.
Publicado: (2011)

Effect of Atorvastatin and Clopidogrel Co-Administration After Coronary Stenting in Korean Patients With Stable Angina
por: Kim, Goeng Bae, et al.
Publicado: (2011)

Cardioprotective Effects of Atorvastatin plus Trimetazidine in Percutaneous Coronary Intervention
por: Lin, Xuefeng, et al.
Publicado: (2013)

Atorvastatin and prevention of contrast induced nephropathy following coronary angiography
por: Bidram, Peyman, et al.
Publicado: (2015)

Effect of Atorvastatin on Serial Changes in Coronary Physiology and Plaque Parameters
por: Lee, Cheol Hyun, et al.
Publicado: (2022)

Evaluation of the Anticipated Burden of COVID-19 on Hospital-Based Healthcare Services Across the United States
por: Khera, Rohan, et al.
Publicado: (2020)

Assessment of Preprint Policies of Top-Ranked Clinical Journals
por: Massey, Dorothy S., et al.
Publicado: (2020)

Enhanced Interaction between Warfarin and High-Dose Ketoconazole: A Case Report
por: Jackevicius, Cynthia A., et al.
Publicado: (2009)

Association of Neighborhood-Level Material Deprivation With Atrial Fibrillation Care in a Single-Payer Health Care System: A Population-Based Cohort Study
por: Abdel-Qadir, Husam, et al.
Publicado: (2022)

The effects of atorvastatin therapy on endothelıal function in patients with coronary artery disease
por: Yildiz, Ahmet, et al.
Publicado: (2007)

Biodegradable Polymers Influence the Effect of Atorvastatin on Human Coronary Artery Cells
por: Strohbach, Anne, et al.
Publicado: (2016)

Comparison of Atorvastatin and Rosuvastatin in Reduction of Inflammatory Markers in Acute Coronary Syndrome
por: Umrani, Salman, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ar1f1fpai2lnhj0p4am7gq7pod